Oncology

THERAPEUTIC EXPERTISE

Oncology

Our capabilities for quality and timely execution of Oncology clinical trials

  • Medical adviser/KOL with >3 decades of experience in the Oncology area
  • Multiple quality checks at each stage of clinical study
  • Access to sites with databases of Oncology patients with an excellent regulatory track record
  • Management of complex drug supply to multiple sites
  • Effective site distribution and naïve site development in competitive studies to avoid recruitment challenges

EXPERIENCE

Therapeutic Areas

  • Metastatic breast cancer
  • Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Colorectal cancer
  • Prostate cancer
  • Ovarian cancer

25+ early phase studies on complex injectable and solid oral formulations across 150+ sites

Ten 505(b)(2) programs ranging from early phase trials to complex phase III trials

Sample size ranging from 16 to 120 patients

Patient drop-out rate of <10%

Rescue PK study with start-up activities completed in <1 month

SCIENTIFIC ADVISORY BOARD

Dr Ravi PatelFounder & Managing Director - Comprehensive Blood & Cancer Center

Dr Chirag DesaiFounder Director - Vedanta Institute of Medical Sciences

SCIENTIFIC ADVISORY BOARD
REQUEST FOR PORPOSAL